JCR Pharmaceuticals Co., Ltd.
JCRRF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $84,860,970 | $171,068,120 | $171,590,788 | $270,164,689 |
| - Cash | $13,196,000 | $18,756,000 | $13,278,000 | $30,733,000 |
| + Debt | $38,105,000 | $23,300,000 | $22,800,000 | $18,100,000 |
| Enterprise Value | $109,769,970 | $175,612,120 | $181,112,788 | $257,531,689 |
| Revenue | $33,072,000 | $42,871,000 | $34,343,000 | $51,082,000 |
| % Growth | -22.9% | 24.8% | -32.8% | – |
| Gross Profit | $21,738,000 | $31,251,000 | $25,457,000 | $40,621,000 |
| % Margin | 65.7% | 72.9% | 74.1% | 79.5% |
| EBITDA | -$2,885,000 | $10,528,000 | $7,453,000 | $21,394,000 |
| % Margin | -8.7% | 24.6% | 21.7% | 41.9% |
| Net Income | -$4,759,000 | $5,507,000 | $3,772,000 | $14,507,000 |
| % Margin | -14.4% | 12.8% | 11% | 28.4% |
| EPS Diluted | -38.43 | 43.92 | 30.22 | 116.79 |
| % Growth | -187.5% | 45.3% | -74.1% | – |
| Operating Cash Flow | -$5,486,000 | $9,312,000 | -$5,500,000 | $9,289,000 |
| Capital Expenditures | -$9,888,000 | -$2,095,000 | -$8,560,000 | -$11,333,000 |
| Free Cash Flow | -$15,374,000 | $7,217,000 | -$14,060,000 | -$2,044,000 |